Trusted by
How Curewiki Can Support Your Mission
Curewiki offers for free tailored solutions designed to meet your needs in various ways.
Strengthen Your Impact
Expanding your network and building awareness can be challenging. By partnering with Curewiki, your organization can gain visibility through our network, attract new members, and participate in collaborative campaigns to raise funds and amplify your mission.
_edited.jpg)
_edited.jpg)
Educate & Engage Your Members
Limited resources shouldn’t limit your ability to educate your members. Curewiki offers ready-made articles, newsletters, and webinars that you can share with your community to raise awareness about clinical trials and their benefits.
Simplify Trial Search
Guiding members through clinical trial options doesn’t have to be resource-intensive. Our real-time chat tool provides personalized trial recommendations directly on your website, streamlining the process and enhancing member support.
_edited.jpg)
Help your members
Helping your members find clinical trials can be complex and time-consuming. With Curewiki’s customizable trial list embedded on your website, you can filter trials by disease, location, and language, making it simple for your members to find the opportunities that matter most.
Finding relevant clinical research isn’t easy for patients or those who support them. At Curewiki, our mission is to bridge the gap between patient organizations and researchers, ensuring patients have better access to the trials that matter most.
Jean-Sebastien Gosuin
CEO of Curewiki and cancer survivor
FAQ
About Curewiki.
Curewiki is a patient-centric platform dedicated to making clinical trials accessible to all. We are fully independent from pharmaceutical companies, ensuring transparency and trust.
Our mission is to connect patients with the Researches that meet their needs while supporting patient organizations in their vital work.
Founded in 2022, by Jean Sebastien Gosuin, Curewiki is a European startup with a 17-member team across Europe and funded by public and private sources.
